Evolution of hepatitis C viral quasispecies after liver transplantation

Gastroenterology. 2002 Nov;123(5):1485-93. doi: 10.1053/gast.2002.36546.

Abstract

Background & aims: To determine whether HCV quasispecies diversity correlated positively with liver disease progression after orthotopic liver transplantation (OLT).

Methods: We studied 11 patients undergoing OLT for HCV-related cirrhosis with recurrent hepatitis C in 2 groups according to the stage of hepatic fibrosis on follow-up. The mild group had stage 1 or 2 fibrosis; the severe group, stage 3 or 4 fibrosis. HCV quasispecies diversity was assessed by cloning and sequencing in pretransplantation and posttransplantation serum samples.

Results: In the mild fibrosis group, intrasample hypervariable region 1 (HVR1) genetic distance and nonsynonymous substitutions increased after OLT, whereas in the severe fibrosis group, these parameters decreased in follow-up. In contrast, intrasample diversity progressed similarly in both groups in the adjacent sequences flanking HVR1. There was an inverse correlation between the stage of hepatic fibrosis and amino acid complexity after OLT. Among all patients, the estimated rate of amino acid change was greater initially and became more constant after 36 months.

Conclusions: After OLT, a more complex HCV HVR1 quasispecies population was associated with mild disease recurrence. Among those patients with severe recurrent hepatitis C, HCV appeared to be under greater immune pressure. The greatest change in viral amino acid sequences occurred in the first 36 months after OLT.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Amino Acid Sequence / genetics
  • Biological Evolution*
  • Fibrosis
  • Genetic Variation*
  • Hepacivirus / genetics*
  • Hepatitis C / complications
  • Humans
  • Liver / pathology
  • Liver Cirrhosis / pathology
  • Liver Cirrhosis / virology
  • Liver Transplantation*
  • Middle Aged
  • Phylogeny
  • Postoperative Period
  • RNA, Viral / genetics
  • Recurrence
  • Reoperation
  • Severity of Illness Index
  • Viral Proteins / genetics

Substances

  • HVR1 protein, Hepatitis C virus
  • RNA, Viral
  • Viral Proteins